Mellissa J Nixon

4PUBLICATIONS
30CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 23, 2020
Changes in Peripheral and Local Tumor Immunity after Neoadjuvant Chemotherapy Reshape Clinical Outcomes in Patients with Breast Cancer.

Margaret L Axelrod, Mellissa J Nixon, Paula I Gonzalez-Ericsson

|Oct 03, 2018
Extended Adjuvant Therapy with Neratinib Plus Fulvestrant Blocks ER/HER2 Crosstalk and Maintains Complete Responses of ER+/HER2+ Breast Cancers: Implications to the ExteNET Trial.

Dhivya R Sudhan, Luis J Schwarz, Angel Guerrero-Zotano

|Aug 11, 2017
Genomic profiling of ER+ breast cancers after short-term estrogen suppression reveals alterations associated with endocrine resistance.

Jennifer M Giltnane, Katherine E Hutchinson, Thomas P Stricker

Pageof 1